The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATE DIAGNOSTICS, INC. | Common | 00430H102 | 2,426 | 112,885 | SH | SOLE | 112,885 | 0 | 0 | ||
| AEGERION PHARMACEUTICALS INC | Common | 00767E102 | 7,405 | 733,125 | SH | SOLE | 733,125 | 0 | 0 | ||
| AGENUS - INC | Common | 00847G705 | 9,984 | 2,199,137 | SH | SOLE | 2,199,137 | 0 | 0 | ||
| ALLIQUA BIOMEDICAL INC | Common | 019621200 | 1,796 | 839,100 | SH | SOLE | 839,100 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 34,101 | 3,515,611 | SH | SOLE | 3,515,611 | 0 | 0 | ||
| AXOVANT SCIENCES LTD. | Common | G0750W104 | 5,536 | 307,070 | SH | SOLE | 307,070 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC. | Common | 14888D109 | 224 | 71,500 | SH | SOLE | 71,500 | 0 | 0 | ||
| CELLECTIS - ADR | Sponsored ADS | 15117K103 | 1,086 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| DERMIRA INC | Common | 24983L104 | 12,285 | 354,950 | SH | SOLE | 354,950 | 0 | 0 | ||
| EGALET CORPORATION. | Common | 28226B104 | 4,767 | 432,606 | SH | SOLE | 432,606 | 0 | 0 | ||
| FORTRESS BIOTECH INC. | Common | 34960Q109 | 3,733 | 1,337,869 | SH | SOLE | 1,337,869 | 0 | 0 | ||
| INNOCOLL AG | Sponsored ADR | 45780Q103 | 4,164 | 501,722 | SH | SOLE | 501,722 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO. | Common | 503459604 | 21,173 | 784,199 | SH | SOLE | 784,199 | 0 | 0 | ||
| LION BIOTECHNOLOGIES INC | Common | 53619R102 | 24,608 | 3,187,607 | SH | SOLE | 3,187,607 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC. | Common | 60468T105 | 39,755 | 1,258,055 | SH | SOLE | 1,258,055 | 0 | 0 | ||
| NANTKWEST- INC | Common | 63016Q102 | 8,828 | 599,287 | SH | SOLE | 599,287 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | 7,184 | 127,000 | SH | SOLE | 127,000 | 0 | 0 | ||
| NEURODERM LTD. | Common | M74231107 | 8,866 | 520,022 | SH | SOLE | 520,022 | 0 | 0 | ||
| ONCOTHYREON INC | Common | 682324108 | 9,144 | 4,119,072 | SH | SOLE | 4,119,072 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS | Common | 71426V108 | 15,178 | 5,144,916 | SH | SOLE | 5,144,916 | 0 | 0 | ||
| SAREPTA THERAPEUTICS -INC | Common | 803607100 | 544 | 39,000 | SH | Call | SOLE | 39,000 | 0 | 0 | |
| SAREPTA THERAPEUTICS -INC | Common | 803607100 | 2 | 800 | SH | Call | SOLE | 800 | 0 | 0 | |
| SAREPTA THERAPEUTICS -INC | Common | 803607100 | 80 | 7,500 | SH | Call | SOLE | 7,500 | 0 | 0 | |
| SAREPTA THERAPEUTICS -INC | Common | 803607100 | 19,406 | 503,007 | SH | SOLE | 503,007 | 0 | 0 | ||
| SORRENTO THERAPEUTICS INC | Common | 83587F202 | 9,987 | 1,146,579 | SH | SOLE | 1,146,579 | 0 | 0 | ||
| TELIGENT INC. | Common | 87960W104 | 12,222 | 1,373,294 | SH | SOLE | 1,373,294 | 0 | 0 | ||
| TONIX PHARMACEUTICALS HLDG | Common | 890260201 | 2,610 | 340,300 | SH | SOLE | 340,300 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 3,199 | 253,697 | SH | SOLE | 253,697 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | 11,738 | 1,260,809 | SH | SOLE | 1,260,809 | 0 | 0 | ||
| VERACYTE INC | Common | 92337F107 | 5,338 | 741,353 | SH | SOLE | 741,353 | 0 | 0 | ||
| VERICEL CORP. | Common | 92346J108 | 2,929 | 1,135,120 | SH | SOLE | 1,135,120 | 0 | 0 | ||